Increased evidence of the importance of aldosterone in the pathogenesis of various diseases has made it attractive to look for its inhibitors. Two kinds of inhibitors have been reported:1) the inhibition of aldosterone effect on sodium resorption by distal tubule of kindney and 2) the inhibition of biosynthesis or secretion of aldosterone by adrenal cortex. Spirolactones (Kagawa et al., 1957; Liddle, 1957) and progesterone (Landau et al., 1955; 1958) belong to these compounds of the first category. They do not inhibit the secretion of aldosterone or other adrenal corticoids (Coppage et al., 1960) . On the contrary, a compensatory increase in aldosterone secretion rate has been reported following administration of spirolactones (Singer, 1959) .
Most of the inhibitors of the second category, paticularly pyridine derivatives, (Raman et al., 1966 ) cannot be used for aldosterone suppression in humans because of toxicity or poor specificity. Only heparin and some related polysulfated polysaccharides show great promise of clinical use (Beiglbock et al., 1952; Schlatmann et al., 1960; Glaz et al., 1964; Sharma et al., 1967) .
In search of the glomerrlotropic factor (GTF) in the pineal gland, Farrell et al.(Farrell, 1960) found that certain extracts of pineal tissue contained an aldosterone inhibitor in lipid fractions which suppressed the activity of GTF for the secretion of aldosterone. Recently (1965), Fabre et al., succeeded in purifying and identifying the inhibitor as ubiquinone. We had a case of Conn's syndrome (Kumagai, 1967) in which hypokalemia and other accompanying symptoms were suprisingly improved by the treatment with ubiquinone.
In the present study, the effect of ubiquinone on the conversion of progesterone and corticosterone to 18-hydroxycorticosterone and aldosterone has been investigated in the rat adrenal. 
Results
When progesterone-4-14C was incubated with the adrenal tissue, the following metabolites could be detected by the column chromatography:18-hydroxycorticosterone, corticosterone + aldosterone, 11-hydroxyprogesterone, DOC and progesterone. The formation of the last three steroids were very little affected by the addition of 1.0mg of ubiquinone in vitro. On the other hand, the peak of 18-hydroxycorticosterone was greatly reduced by ubiquinone, while that of corticosterone + aldosterone were increased by ubiquinone (Fig. 1 ). Paper chromatography of corticosterone aldosterone Typical examples of the column chromatography of some authorized materials of steroid are shown on top. The other curves are isotopic patterns of metabolites from progesterone-4-14C after incubation of rat adrenal slices without Co Q7 (Control) and with Co Q7. Incubation were done under the condition described in Materials and Methods.
the fraction of corticosterone aldosterone provided an evidence of the fact that this increase was attributable only to corticosterone and the production of 18-hydroxycorticosterone and aldosterone was clearly reduced by ubiquinone (Fig. 2, 3) .
When corticosterone-1, 2-3H was used as the substrate, only two peaks of steroids, 18-hydroxycorticosterone and corticosterone aldosterone, were detected by the column chromatography. The peak of 18-hydroxycorticosterone was decreased by 0.1 and 1.0 mg of ubiquinone and the effect seemed to be dose-dependent (Fig. 4) . The second peak was unaffected by ubiquinone, but paper chromatography of the fraction showed that the production of aldosterone and 18-hydroxycorticosterone was decreased by 1.0mg of ubiquinone (Fig. 5, 6 ).
If the ratios of the formed metabolites to the added substrate after the incubation are calculated, the effect and site of action of ubiquinone can be more clearly shown. The ratio of corticosterone to progesterone was increased by 4 times by ubiquinone, while the ratio of 18-hydroxycorticosterone aldosterone to progesterone was decreased to less than half of that of the control (Table 1) . Both ratios of 18-hydroxycorticosterone and of aldosterone to corticosterone were decreased by the addition of ubquinone (Table 2) . Therefore, it is reasonably concluded that Typical examples of the column chromatography of corticosterone, aldosterone and 11-OHprogesterone are shown (upper, left). The other curves are isotopic patterns of metabolites from corticosterone-1,2-3H after incubation of rat adrenal slices without Co Q7 (Control) and with Co Q7 0.1mg and 1.0mg respectively. Incubation were under the condition described in Materials and Methods. 
Discussion
In 1960, Farrell (Farrell, 1960) reported that certain extracts of pineal tissue administered intravenously inhibited steroidgenesis in the dog. Five years later, the same author and his coworkers, demonstrated (Fabre et al., 1965 ) that ubiquinone, a constituent of the lipid fraction of beef pineal gland, was mainly responsible for this inhibition. Clinical trial of ubiquinone has been given in our hands for the control of hyperaldosteronism (Kumagai, 1967) . In a case of Conn's syndrome the symptoms such as hypokalemia, headache, weakness, etc. were surprisingly improved by treatment with ubiquinone 100mg/day for a week. Many cases of heart failure responded fairly well to the administration of ubiquinone (Yamamura et al., 1967) . Encouraged by these clinical observations as well as Farrell's reports, we have undertaken the present experiment to see the effect of ubiquinone on the in vitro biosynthesis of aldosterone by the rat adrenal tissue.
It is generally accepted that 18-hydroxycorticosterone is the main intermediate on the biosynthetic pathway between corticosterone and aldosterone though the details are still remained unknown. NADPH is required as an indispensable cofactor this metabolic process as in other steps of steroid hydroxylation. A recent report of Greengard et al (Greengard et al., 1967) indicated that cytochrome P-450, a component of mixed function oxidase system requiring NADPH, is involved in the biosynthesis of aldosterone from corticosterone by adrenal mitochondria. As ubiquinone is found in adrenal mitochondria, it is quite concevable that it can act as a hydrogen trap for NADPH to inhibit the adrenal systems by which aldosterone is produced. However, if this is true, every step of steroid hydroxylation should be equally inhibited. Since the inhibition by ubiquinone is rather specific for 18-hydroxylation and NADPH is added exogenously to the incubation system in the present experiment, this possibility for the mechanism of inhibition can be excluded. Other factors such as calcium (Buddecke and Dryzenick, 1962) or renin-angiotension system (Schlatmann et al., 1964; Sealey et al., 1967) which were proposed for the action of heparin, can also be excluded for the mechanism of ubiquinone in the present in vitro experiment . Thus, at present, the direct inhibition of 18-hydroxylase in the adrenal cell would be the most probable mechanism of inhibitory action of ubiquinone.
The clinical application of ubiquinone is very interesting because of its potential use to combat hyperaldosteronism of various causes. Spirolactones are now the first choice in the treatment of secondary hyperaldosteronism. The diuretic effect of spirolactones is sometimes quite dramatic for edema of secondary hyperaldosteronism. But, as they have no direct effect on the secretion or production of aldosterone by the adrenal cortex, the effect is
